Citations

Clear

382 citation(s) found for "Li, Man".

Effect of 2 Years of Testosterone Replacement on Insulin Secretion, Insulin Action, Glucose Effectiveness, Hepatic Insulin Clearance, and Postprandial Glucose Turnover in Elderly Men
Basu, Rita , Man, Chiara Dalla , Campioni, Marco, Basu, Ananda , Jensen, Michael D. , Khosla, Sundeep , Klee, George G., Toffolo, Gianna , Rizza, Robert A., Nair, K. Sreekumaran , Cobelli, Claudio , Dalla Man, Chiara , Khosla, Sundeep

Mayo Clinic

Diabetes Care | July 28, 2007 | Volume: 30 | Issue: 8 | Pages: 1972-1978

10.2337/dc07-0359 | PMID 17496236 Get It

OBJECTIVE—We sought to determine whether, and if so the mechanism by which, testosterone replacement improves carbohydrate tolerance. RESEARCH DESIGN AND METHODS—Fifty-five elderly men with relative testosterone deficiency ingested a labeled mixed meal and underwent a frequently sampled labeled intravenous glucose tolerance test before and after either placebo or treatment with testosterone patch (5 mg/day) for 2 years. RESULTS—Despite restoring bioavailable testosterone to values observed in young men, the change (24 months minus baseline values) in fasting and postprandial glucose, insulin, and C-peptide concentrations and meal appearance, glucose disposal, and endogenous glucose production were virtually identical to those observed after 2 years of placebo. The change over time in insulin and C-peptide concentrations post–intravenous glucose injection also did not differ. Furthermore, the change over time in insulin action and glucose effectiveness (measured with the unlabeled and labeled “oral” and “intravenous” minimal models), as well as insulin secretion and hepatic insulin clearance (measured with the C-peptide model), did not differ in the testosterone and placebo groups. CONCLUSIONS—We conclude that 2 years of treatment with testosterone in elderly men does not improve carbohydrate tolerance or alter insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, or the pattern of postprandial glucose metabolism. Thus, testosterone deficiency is unlikely the cause of the age-associated deterioration in glucose tolerance commonly observed in elderly men.
An 81-year-old man with imbalance and memory impairment
Golbe, Lawrence I. , Parisi, Joseph E., Boeve, Bradley F. , Keegan, B. Mark

Mayo Clinic

Neurology | April 2, 2007 | Volume: 68 | Issue: 14 | Pages: 1147-1152

10.1212/01.wnl.0000261479.73872.6a | PMID 17404198 Get It

Effects of Nonglucose Nutrients on Insulin Secretion and Action in People With Pre-Diabetes
Bock, Gerlies, Man, Chiara Dalla , Campioni, Marco, Chittilapilly, Elizabeth, Basu, Rita , Toffolo, Gianna , Rizza, Robert A., Treiber, Gerlies , Cobelli, Claudio , Dalla Man, Chiara

Mayo Clinic

Diabetes | March 29, 2007 | Volume: 56 | Issue: 4 | Pages: 1113-1119

10.2337/db06-1272 | PMID 17395750 Get It

To determine whether nonglucose nutrient–induced insulin secretion is impaired in pre-diabetes, subjects with impaired or normal fasting glucose were studied after ingesting either a mixed meal containing 75 g glucose or 75 g glucose alone. Despite comparable glucose areas above basal, glucose-induced insulin secretion was higher (P < 0.05) and insulin action lower (P < 0.05) during the meal than the oral glucose tolerance test (OGTT) in all subgroups regardless of whether they had abnormal or normal glucose tolerance (NGT). However, the nutrient-induced δ (meal minus OGTT) in insulin secretion and glucagon concentrations did not differ among groups. Furthermore, the decrease in insulin action after meal ingestion was compensated in all groups by an appropriate increase in insulin secretion resulting in disposition indexes during meals that were equal to or greater than those present during the OGTT. In contrast, disposition indexes were reduced (P < 0.01) during the OGTT in the impaired glucose tolerance groups, indicating that reduced glucose induced insulin secretion. We conclude that, whereas glucose-induced insulin secretion is impaired in people with abnormal glucose tolerance, nonglucose nutrient–induced secretion is intact, suggesting that a glucose-specific defect in the insulin secretory pathway is an early event in the evolution of type 2 diabetes.
Two-Hour Seven-Sample Oral Glucose Tolerance Test and Meal Protocol
Man, Chiara Dalla , Campioni, Marco, Polonsky, Kenneth S., Basu, Rita , Rizza, Robert A., Toffolo, Gianna , Cobelli, Claudio , Dalla Man, Chiara

Mayo Clinic

Diabetes | March 6, 2007 | Volume: 54 | Issue: 11 | Pages: 3265-3273

10.2337/diabetes.54.11.3265 | PMID 16249454 Get It

Highly informative yet simple protocols to assess insulin secretion and action would considerably enhance the quality of epidemiological and large-scale clinical trials. In an effort to develop such protocols, a 5-h, 11-sample oral glucose tolerance test (OGTT) was performed in 100 individuals and a 7-h, 21-sample meal in another 100. Plasma glucose, insulin, and C-peptide concentrations were measured. We show that virtually the same minimal model assessment of β-cell responsivity (dynamic [Φd] and static [Φs]), insulin sensitivity (Si), and disposition index (DI) can be obtained with a reduced seven-sample 2-h protocol: Φd, reduced versus full: 871.50 vs. 873.32, r = 0.98 in OGTT and 494.88 vs. 477.99 10−9, r = 0.91 in meal; Φs: 42.36 vs. 44.35, r = 0.88 in OGTT and 35.31 vs. 35.37 10−9 min−1, r = 0.90 in meal; Si: 24.33 vs. 22.77 10−5 dl · kg−1 · min−1 per pmol/l, r = 0.89 in OGTT and 19.03 vs. 19.77 10−5 dl · kg−1 · min−1 per pmol/l, r = 0.85 in meal; and DI: 1,282.26 vs. 1,273.23, r = 0.84 in OGTT and 726.92 vs. 776.97 10−14 dl · kg−1 · min−2 per pmol/l, r = 0.84 in meal. This reduced protocol will facilitate the study of insulin secretion and action under physiological conditions in nondiabetic humans.
A 63-year-old man with headaches and behavioral deterioration
Greenberg, Steven M. , Parisi, Joseph E. , Keegan, B. Mark

Mayo Clinic

Neurology | March 5, 2007 | Volume: 68 | Issue: 10 | Pages: 782-787

10.1212/01.wnl.0000258985.31455.13 | PMID 17339589 Get It

SIMCON—simulation control to optimize man-machine interaction
Anderson, Dennis U., Knopp, T. J., Bassingthwaighte, James B.

Mayo Clinic

SIMULATION | March 4, 2007 | Volume: 14 | Issue: 2 | Pages: 81-86

10.1177/003754977001400205 | PMID 21423785 Get It

The fitting of mathematical models to physiological sys tems can be tedious and difficult, whether one uses analog or digital computer methods. Both methods have their pros and cons depending on the available hardware and software and on the type of modeling. In recent years many digital simulation languages have been written com bining analog-like and digital features to facilitate model ing, but, for a variety of reasons, none of these was suit able for our applications. We, therefore, designed a new digital simulation control system, SIMCON, which is de scribed in this paper. The primary objectives were to provide: (1) Maximum man-machine interaction at run-time, in cluding visual displays, digital control, and both con tinuous analog and digital parameter adjustment (2) The ability to generate solutions and to fit them to experimental data or other theoretical curves with a minimum of computer memory (3) The option to use a mathematically oriented language, FORTRAN, and block operators with variable input/ output. The result is a relatively general and simple simulation system which is easy to use and has wide versatility.
Two Years of Treatment With Dehydroepiandrosterone Does Not Improve Insulin Secretion, Insulin Action, or Postprandial Glucose Turnover in Elderly Men or Women
Basu, Rita , Man, Chiara Dalla , Campioni, Marco, Basu, Ananda , Nair, K. S., Jensen, Michael D. , Khosla, Sundeep , Klee, George G., Toffolo, Gianna , Rizza, Robert A., Cobelli, Claudio , Dalla Man, Chiara , Khosla, Sundeep

Mayo Clinic

Diabetes | February 27, 2007 | Volume: 56 | Issue: 3 | Pages: 753-766

10.2337/db06-1504 | PMID 17327446 Get It

To determine if dehydroepiandrosterone (DHEA) replacement improves insulin secretion, insulin action, and/or postprandial glucose metabolism, 112 elderly subjects with relative DHEA deficiency ingested a labeled mixed meal and underwent a frequently sampled intravenous glucose tolerance test before and after 2 years of either DHEA or placebo. Despite restoring DHEA sulphate concentrations to values observed in young men and women, the changes over time in fasting and postprandial glucose concentrations, meal appearance, glucose disposal, and endogenous glucose production were identical to those observed after 2 years of placebo. The change over time in postmeal and intravenous glucose tolerance test insulin and C-peptide concentrations did not differ in men treated with DHEA or placebo. In contrast, postmeal and intravenous glucose tolerance test change over time in insulin and C-peptide concentrations were greater (P < 0.05) in women after DHEA than after placebo. However, since DHEA tended to decrease insulin action, the change over time in disposition indexes did not differ between DHEA- and placebo-treated women, indicating that the slight increase in insulin secretion was a compensatory response to a slight decrease in insulin action. We conclude that 2 years of replacement of DHEA in elderly men and women does not improve insulin secretion, insulin action, or the pattern of postprandial glucose metabolism.
An 85-year-old man with chronic lymphocytic leukemia and altered mental status
Tyler, Kenneth L. , Aksamit, Allen J. , Parisi, Joseph E. , Keegan, B. Mark

Mayo Clinic

Neurology | February 5, 2007 | Volume: 68 | Issue: 6 | Pages: 460-467

10.1212/01.wnl.0000256093.16015.1a | PMID 17283324 Get It

A 34-year-old man with progressive behavioral and language disturbance
Josephs, Keith A. , Parisi, Joseph E., Miller, Bruce L. , Keegan, B. Mark

Mayo Clinic

Neurology | January 3, 2007 | Volume: 68 | Issue: 1 | Pages: 68-74

10.1212/01.wnl.0000251313.89403.b3 | PMID 17200497 Get It

Pathogenesis of Pre-Diabetes
Bock, Gerlies, Man, Chiara Dalla , Campioni, Marco, Chittilapilly, Elizabeth, Basu, Rita , Toffolo, Gianna , Rizza, Robert A., Treiber, Gerlies , Cobelli, Claudio , Dalla Man, Chiara

Mayo Clinic

Diabetes | November 28, 2006 | Volume: 55 | Issue: 12 | Pages: 3536-3549

10.2337/db06-0319 | PMID 17130502 Get It

Thirty-two subjects with impaired fasting glucose (IFG) and 28 subjects with normal fasting glucose (NFG) ingested a labeled meal and 75 g glucose (oral glucose tolerance test) on separate occasions. Fasting glucose, insulin, and C-peptide were higher (P < 0.05) in subjects with IFG than in those with NFG, whereas endogenous glucose production (EGP) did not differ, indicating hepatic insulin resistance. EGP was promptly suppressed, and meal glucose appearance comparably increased following meal ingestion in both groups. In contrast, glucose disappearance (Rd) immediately after meal ingestion was lower (P < 0.001) in subjects with IFG/impaired glucose tolerance (IGT) and IFG/diabetes but did not differ in subjects with IFG/normal glucose tolerance (NGT) or NFG/NGT. Net insulin action (Si) and insulin-stimulated glucose disposal (Si*) were reduced (P < 0.001, ANOVA) in subjects with NFG/IGT, IFG/IGT, and IFG/diabetes but did not differ in subjects with NFG/NGT or IFG/NGT. Defective insulin secretion also contributed to lower postprandial Rd since disposition indexes were lower (P < 0.001, ANOVA) in subjects with NFG/IGT, IFG/IGT, and IFG/diabetes but did not differ in subjects with NFG/NGT and IFG/NGT. We conclude that postprandial hyperglycemia in individuals with early diabetes is due to lower rates of glucose disappearance rather than increased meal appearance or impaired suppression of EGP, regardless of their fasting glucose. In contrast, insulin secretion, action, and the pattern of postprandial turnover are essentially normal in individuals with isolated IFG.